Page 75 - Sohini Das

Diagnostic industry looks to leverage Covid infra for non-Covid tests

Covid revenues are roughly 10 per cent of large lab chains' turnovers now, claims the industry.

Corporate hospitals chart out plans for expansion via brownfield route

The focus on brownfield expansion and sprucing up existing hospitals is because this requires less investment

Malaria to pneumonia vaccines: SII now betting on non-Covid shots

SII has the capacity to produce 250 million monthly doses of Covishield

Private hospitals to be largest beneficiary of growing healthcare spend

May garner 65-70% of spending pie; Indian healthcare growth momentum likely to continue in FY23 as occupancy improves and average revenue per occupied bed remains steady

Fortis launches workplace mental health programme to deal with distress

Initiative provides counselling, webinars to create a culture of openness and acceptance about mental health and real-time text chat support by a team of psychologists

Tedious road to recovery: Covid is also altering people's signatures

Children, too, are experiencing aftereffects such as sleeplessness, fatigue, brain fog

WPI effect: 800 key drugs likely to see 10% price rise in April

While the NPPA may allow a 10 per cent rise in prices of NLEM drugs based on WPI this year, the actual price rise could be less, say drug firms

WHO includes oral antiviral molnupiravir in Covid-19 treatment guidelines

Invites manufacturers to submit products for pre-qualification

Sputnik Light may soon be only version available in India amid low demand

Meanwhile, local manufacturing partners have either halted or reduced production of Sputnik Light owing to low demand

Endemic: Fourth Covid wave unlikely as immunity levels rise, say experts

Steady and stable infection rate with minor fluctuations for four weeks or more is when the disease is in endemic stage.

Virtual audits will not replace physical inspection, says USFDA

Surprise audits of manufacturing sites too are on the cards

Top pharma firms to hike R&D spend next 5 yrs as mkt eyes $130 bn revenue

Industry captains feel pandemic has opened up opportunities for the sector in India to emerge as a second source of raw material and finished products, after China

Expand PLI scheme for pharma to make it research-linked, says industry

So far 55 drug manufacturers have been selected under the PLI scheme for pharma.

mRNA Covid vax scientist Weissman working on universal coronavirus vaccine

Universal coronavirus Vaccine: University of Pennsylvania's Perelman School of Medicine's Dr Drew Weissman are in talks with India and other countries for building mRNA production sites.

Global community can tap India's Covid vaccine capacity, say firms

Bharat Biotech MD Krishna Ella said India now has four BSL-4 containment facilities, equal to that of the UK.

Booster dose: Dose gap, natural infection slow offtake among 60-plus

Experts are also questioning the nine-month gap between the second and the third doses

India confirms first Omicron-related death as Covid-19 cases jump

As cases continued to rise across the country, several state governments were forced to issue fresh guidelines on restrictions

Molnupiravir not in national clinical protocol due to safety concerns

ICMR chief says task force has debated twice on whether to include the drug in the protocol, but decided against it

Stricter Covid-19 curbs back in India as Omicron cases multiply

Weekend curfew in Delhi; Mumbai warns of lockdown if daily cases cross 20,000

Price war rages as pharma firms despatch Covid-19 antiviral pill

Competitive pricing among firms keeps rates at Rs 1,400-2,490 for full treatment